Chimerix Inc. (NASDAQ: CMRX) Stock Information | RedChip

Chimerix Inc. (NASDAQ: CMRX) Listen to this Section


$1.07
+0.2350 ( +28.14% ) 2.2M

Chimerix Inc. is a biopharmaceutical company based in the United States that engages in the research, development, and commercialization of medicines. Its portfolio includes treatment for acute myeloid leukemia (or AML) and antiviral treatment for smallpox. The company generates revenue through revenue related to non-refundable upfront fees, royalties and milestone payments earned under license agreements, also by royalty revenue related to sales of TEMBEXA made by Emergent after the Asset Sale. The company operates only in one business segment namely pharmaceuticals.

Market Data


Open


$1.07

Previous close


$0.84

Volume


2.2M

Market cap


$91.43M

Day range


$0.84 - $1.06

52 week range


$0.75 - $1.30

Insider Ownership Transactions

Total Amount Purchased: -581,285.00 | $ -621,974.95

Date Type Amount Purchased Purchaser
2024-08-09 Sale -1285.00 Andriole Michael T.
2024-06-21 Sale -60000.00 Meyer Robert J.
2024-06-21 Sale -60000.00 DEMSKI MARTHA J
2024-06-21 Sale -60000.00 Sherman Michael A.
2024-06-21 Sale -60000.00 Decker Lisa Lynn
2024-06-21 Sale -60000.00 Vakiener Victoria
2024-06-21 Sale -60000.00 KOZIN MARC D
2024-06-21 Sale -60000.00 Multani Pratik S
2024-06-21 Sale -60000.00 MIDDLETON FRED A
2024-03-21 Sale -100000.00 KOZIN MARC D

SEC Fillings


Form Type Description Pages Date
8-k 8K-related 51 Aug 13, 2024
10-q Quarterly Reports 54 Aug 13, 2024
4 Insider transactions 1 Aug 09, 2024
8-k 8K-related 13 Jul 03, 2024
8-k 8K-related 13 Jun 21, 2024
4 Insider transactions 1 Jun 21, 2024
4 Insider transactions 1 Jun 21, 2024
4 Insider transactions 1 Jun 21, 2024
4 Insider transactions 1 Jun 21, 2024
4 Insider transactions 1 Jun 21, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.